|
HIV-TB co-infections
- Charles Mgone, EDCTP
Update on activities
Download presentation (PDF 2,640KB) - Nick Paton, MRC Clinical Trials Unit
Optimisation of the treatment of HIV and HIV-TB coinfections
Download presentation (PDF 14,002KB) - Abraham Alabi, USDOD-NMOD HIV Research Programme Abuja, Nigeria
Mecky Matee, Muhimbili University College of Health Science,Tanzania
Strengths and gaps in the areas of TB-HIV coinfection in Africa
Download presentation (PDF 446KB) - Henrique de Barros, Coordenação Nacional para a Infecção VIH/SIDA
HIV/AIDS in Portugal
Download presentation (PDF 1,736KB) - Brigitte Bazin, ANRS
Optimisation of HIV treatment and HIV-TB coinfection: French Programme
Download presentation (PDF 4,975KB) - Frank Cobelens, Academic Medical Center, Amsterdam
The INTERACT Programme
Download presentation (PDF 607KB) - Andreas Meyerhans, Biomedizineche Technik (Germany)/Universitat des Saarlandes/UCONET
Global HIV Vaccine Research Cryorepository
Download presentation (PDF 501KB) - Wolf-Georg Forssmann, Viro Pharma
Preclinical evaluation of VIR-576
Download presentation (PDF 14,778KB) - Friedrich von Massow, UNIDO / Heidelberg Pharma
Increasing access to drugs: the case of Fozivudine
Download presentation (PDF 120KB) - Maurizio Zazzi, University of Siena, Italy
EuResist Network
Download presentation (PDF 1,494KB) - Stefan Svenson, Karolinska Institutet
Karolinska Institutet research in TB-HIV
Download presentation (PDF 691KB) - Bob Colebunders, Institute of Tropical Medicine
Drug resistant TB and HIV
Download presentation (PDF 307KB)
|
